1. Epizyme’s Tazverik (tazemetostat) Receives the US FDA’s Accelerated Approval as the First Therapy for Epithelioid Sarcoma Published: Jan 23, 2020 | Tags: Epizyme, Tazverik, tazemetostat, Receives, US, FDA, Accelerated Approval, […]readmore
Tags : CMS
Shots: Zydus to receive up front, development & commercial milestones and royalties on sales of Desidustat while CMS to get a license to develop & commercialize the therapy for CKD […]readmore